⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25269041 | 1.00 | — | — | |
| SCHEMBL29889093 | 0.85 | ALDH1A1 (0.69) | — | |
| SCHEMBL1494462 | 0.77 | — | — | |
| SCHEMBL7961714 | 0.76 | — | — | |
| SCHEMBL22878567 | 0.75 | — | — | |
| SCHEMBL190439 | 0.75 | — | — | |
| SCHEMBL9207802 | 0.74 | — | — | |
| SCHEMBL13587310 | 0.72 | — | — | |
| SCHEMBL155373 | 0.72 | — | — | |
| SCHEMBL15128367 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-219921563-U | Novel safe portable medicine package | 上海海智工业科技有限公司 | 2023-10-31 | — | — | CN | disclosed |
| US-11217753-B2 | Formation of carbon nanotube-containing devices | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2022-01-04 | — | — | US | disclosed |
| US-11205754-B2 | Formation of carbon nanotube-containing devices | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2021-12-21 | — | — | US | disclosed |
| US-11189798-B2 | Formation of carbon nanotube-containing devices | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2021-11-30 | — | — | US | disclosed |
| US-11127903-B2 | Formation of carbon nanotube-containing devices | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2021-09-21 | — | — | US | disclosed |
| US-20190288210-A1 | FORMATION OF CARBON NANOTUBE-CONTAINING DEVICES | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2019-09-19 | — | — | US | disclosed |
| US-20190288211-A1 | FORMATION OF CARBON NANOTUBE-CONTAINING DEVICES | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2019-09-19 | — | — | US | disclosed |
| US-10367146-B2 | Formation of carbon nanotube-containing devices | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2019-07-30 | — | — | US | disclosed |
| US-20190165277-A1 | FORMATION OF CARBON NANOTUBE-CONTAINING DEVICES | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2019-05-30 | — | — | US | disclosed |
| US-20190165276-A1 | FORMATION OF CARBON NANOTUBE-CONTAINING DEVICES | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2019-05-30 | — | — | US | disclosed |
| US-20150105475-A1 | POINT OF USE GENERATION OF AMYL NITRITE | SOUTHWEST RESEARCH INSTITUTE | 2015-04-16 | — | — | US | disclosed |
| US-20150105474-A1 | ISOAMYL NITRITE FORMULATIONS | SOUTHWEST RESEARCH INSTITUTE | 2015-04-16 | — | — | US | disclosed |
| US-8987496-B1 | Point of use generation of amyl nitrite | SOUTHWEST RESEARCH INSTITUTE (US) | 2015-03-24 | — | — | US | disclosed |
| EP-2513118-A1 | BICYCLIC THIAZOLES AS ALLOSTERIC MODULATORS OF MGLUR5 RECEPTORS | Janssen Pharmaceutica, N.V. (BE) | 2012-10-24 | — | — | EP | disclosed |
| EP-2513117-A1 | BICYCLIC THIAZOLES AS ALLOSTERIC MODULATORS OF MGLUR5 RECEPTORS | Janssen Pharmaceutica, N.V. (BE) | 2012-10-24 | — | — | EP | disclosed |
| WO-2011073347-A1 | BICYCLIC THIAZOLES AS ALLOSTERIC MODULATORS OF MGLUR5 RECEPTORS | JANSSEN PHARMACEUTICA NV (BE) | 2011-06-23 | — | — | WO | disclosed |
| WO-2011073339-A1 | BICYCLIC THIAZOLES AS ALLOSTERIC MODULATORS OF MGLUR5 RECEPTORS | JANSSEN PHARMACEUTICA NV (BE) | 2011-06-23 | — | — | WO | disclosed |
| EP-2001480-A2 | INDAZOLE COMPOUNDS | Abbott Laboratories (US) | 2008-12-17 | — | — | EP | disclosed |
| WO-2007117465-A2 | INDAZOLE COMPOUNDS | ABBOTT LABORATORIES (US) | 2007-10-18 | — | — | WO | disclosed |
| US-3939294-A | ISOCYANATE AND PROMOTER | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1976-02-17 | — | — | US | disclosed |